A prostate cancer diagnosis can leave patients with an important question: What treatment should I choose?

The answer is rarely based on the cancer diagnosis alone. Prostate cancer can behave very differently from one person to another, and treatment decisions depend on factors such as the cancer's risk group and stage, PSA level, biopsy findings, overall health, age and life expectancy, previous treatment, and whether the cancer has spread beyond the prostate.

For some men with lower-risk disease, active surveillance or observation may be considered instead of immediate treatment. For others, surgery or radiation may be appropriate. If the cancer has spread or returned, medical treatments such as hormone therapy, chemotherapy, targeted therapy or immunotherapy may become part of the treatment plan.

The goal is not simply to identify a treatment that is available. It is to understand which approach fits the individual cancer and the patient's circumstances.

At Medicover Cancer Institute, Arilova, Visakhapatnam, prostate cancer is included within its uro-oncology services, with access to medical oncology, surgical oncology and radiation oncology.

What Is Prostate Cancer?

The prostate is a small gland located below the bladder and in front of the rectum. It forms part of the male reproductive system.

Prostate cancer develops when abnormal cells in the prostate grow in an uncontrolled way. Some prostate cancers grow slowly and may never cause significant problems, while others can grow more aggressively and spread to other parts of the body.

This variation is one reason treatment cannot be determined from the word "cancer" alone.

Doctors may consider information including:

• PSA test results
• Prostate examination
• Biopsy findings
• Gleason grade or Grade Group
• Cancer stage
• Imaging findings
• Whether cancer is confined to the prostate
• Whether nearby lymph nodes are involved
• Whether cancer has spread elsewhere
• Age and general health
• Previous treatments
• Patient preferences and treatment goals

Risk grouping and staging help the cancer team understand how likely the disease is to grow or spread and which treatment approaches may be appropriate.

Does Every Prostate Cancer Need Immediate Treatment?

No.

Some prostate cancers are considered sufficiently low risk that active surveillance may be appropriate.

Active surveillance does not mean ignoring the cancer. Instead, the patient undergoes scheduled monitoring, which may involve PSA testing, examinations, imaging and, when appropriate, repeat biopsy or other investigations. Treatment can then be considered if there are signs that the cancer is changing.

Watchful waiting is another approach. It is generally less intensive than active surveillance and may be considered in situations where the focus is on monitoring the patient's condition and treating symptoms if they develop.

The distinction matters because immediate surgery or radiation is not automatically necessary for every prostate cancer diagnosis.

When Is Prostate Cancer Surgery Considered?

For selected men whose cancer is confined to the prostate and who are suitable candidates for surgery, doctors may consider radical prostatectomy.

Radical prostatectomy involves removing the prostate gland and surrounding structures as appropriate. Nearby lymph nodes may also be assessed or removed in selected cases.

Surgery may be discussed particularly when:

• The cancer is localized.
• The patient's overall health makes surgery a reasonable option.
• The expected benefits of removing the prostate outweigh the potential risks.
• The patient prefers a surgical approach after discussing alternatives.
• The cancer's characteristics indicate that definitive local treatment is appropriate.

However, surgery is not automatically the right choice simply because the cancer is localized.

Patients should discuss possible effects on urinary control, sexual function and fertility before undergoing radical prostatectomy. These issues are important parts of treatment planning, rather than considerations to address only after surgery.

What Happens After Prostate Cancer Surgery?

Follow-up usually involves monitoring the patient's recovery and checking for evidence of remaining or returning disease.

PSA testing is an important component of follow-up after radical prostatectomy because the prostate has been removed and PSA should generally become very low or undetectable.

If the cancer shows signs of returning, additional treatment such as radiation or systemic therapy may sometimes be considered depending on the clinical situation.

When Is Radiation Therapy Used for Prostate Cancer?

Radiation therapy uses high-energy radiation to damage cancer cells.

For prostate cancer, radiation may be used as a treatment for localized or locally advanced disease, and it can also have a role in controlling symptoms when cancer has spread.

Depending on the patient's situation, radiation may include external-beam radiation or other forms of radiation treatment.

At Medicover Cancer Institute, Arilova, the hospital lists Radiation Oncology and advanced radiation techniques including IMRT, IGRT, SBRT and SRS, where clinically applicable.

What Are IMRT and IGRT?

IMRT, or intensity-modulated radiation therapy, allows radiation intensity to be varied across different parts of the treatment field.

IGRT, or image-guided radiation therapy, uses imaging during the treatment process to help guide radiation delivery.

These techniques are intended to support accurate treatment planning and delivery. Whether a particular radiation technique is appropriate depends on the cancer and the radiation oncologist's assessment.

Radiation treatment can also have side effects. Depending on the technique and individual circumstances, patients may experience urinary, bowel or sexual side effects. These should be discussed before treatment.

When Is Medical Therapy Used?

Medical therapy refers to treatments that use medicines to control cancer.

For prostate cancer, medical treatment can include:

• Hormone therapy
• Chemotherapy
• Targeted therapy
• Immunotherapy in selected situations
• Other systemic treatments depending on the cancer's characteristics

The appropriate treatment depends heavily on whether the cancer is localized, locally advanced, recurrent or metastatic.

Hormone Therapy

Prostate cancer cells can be influenced by male hormones called androgens, particularly testosterone.

Hormone therapy, also called androgen-deprivation therapy in many contexts, works by reducing androgen activity.

It may be used:

• Alongside radiation for selected localized or locally advanced cancers
• For recurrent disease
• For advanced prostate cancer
• When cancer has spread
• In combination with other systemic treatments in appropriate situations

Hormone therapy is not used in exactly the same way for every patient. The timing, duration and combination with other treatments depend on the cancer and the patient's circumstances.

Chemotherapy

Chemotherapy uses medicines that affect rapidly dividing cancer cells.

It is not required for every man with prostate cancer. It may be considered particularly in advanced disease or specific higher-risk treatment situations.

The decision depends on disease extent, previous treatment, overall health and the broader treatment strategy.

Targeted Therapy and Immunotherapy

Some prostate cancers have biological or genetic characteristics that may make particular targeted treatments appropriate.

Immunotherapy may also be considered in selected circumstances.

These treatments are not appropriate for every prostate cancer patient. Their use depends on factors such as cancer characteristics, previous treatment, biomarkers and the available clinical evidence.

Surgery vs Radiation vs Medical Therapy: How Are They Different?

There is no universally superior prostate cancer treatment.

The appropriate approach depends on the individual cancer.

Treatment selection should be based on the patient's risk group, stage, cancer characteristics, overall health and treatment goals, rather than choosing a procedure based only on its name.

How Do Doctors Choose the Right Prostate Cancer Treatment?

This is often the most important part of the treatment discussion.

A cancer specialist may consider several questions.

1. Is the cancer confined to the prostate?

If the disease appears localized, local treatments such as surgery or radiation may be considered in appropriate patients.

2. What is the cancer's risk group?

PSA, biopsy findings, Grade Group and other clinical information help classify the cancer's risk.

3. Has the cancer spread?

If cancer has spread to lymph nodes, bones or other organs, the treatment strategy may be different from that used for localized disease.

4. What is the patient's overall health?

Age alone does not determine treatment. Doctors also consider general health, other medical conditions, life expectancy and ability to tolerate treatment.

5. What are the patient's priorities?

For some patients, avoiding or delaying treatment-related side effects may be particularly important. Others may prioritize definitive treatment when clinically appropriate.

6. Could more than one treatment be needed?

Yes.

Prostate cancer treatment does not always involve choosing exactly one treatment. Depending on the disease, surgery, radiation and medical therapy can sometimes be combined or used sequentially.

Tests Used Before Prostate Cancer Treatment

Before choosing treatment, doctors need enough information to understand the cancer accurately.

Evaluation may include:

PSA Blood Test

PSA, or prostate-specific antigen, is a protein produced by prostate cells. PSA testing can contribute to prostate cancer evaluation and monitoring, but an elevated PSA does not automatically mean cancer.

Digital Rectal Examination

A clinician may examine the prostate through the rectum to assess its size and physical characteristics.

Prostate Biopsy

A biopsy involves collecting tissue samples from the prostate so that a pathologist can examine them for cancer.

The biopsy can provide information about the grade and characteristics of the cancer, which helps guide treatment decisions.

MRI and Other Imaging

MRI can provide detailed information about the prostate and may help with diagnostic assessment and treatment planning.

Depending on the clinical situation, CT, PET-CT or other imaging may also be considered.

Medicover Cancer Institute, Arilova, lists MRI, CT, ultrasound, 4D PET-CT, digital X-ray and nuclear medicine among its diagnostic and medical technology capabilities.

Not every patient needs every scan.

Prostate Cancer Treatment at Medicover Cancer Institute, Arilova

Medicover Cancer Institute in Arilova, Visakhapatnam lists Uro Oncology as one of its specialist cancer services, with prostate cancer specifically included among the conditions covered by its oncology information.

The institute's published services include:

• Medical Oncology
• Surgical Oncology
• Radiation Oncology
• Uro Oncology
• Hemato-Oncology
• Thoracic Oncology
• Breast Oncology
• Oncoplastic Surgery
• Pediatric Oncology
• Bone marrow and stem-cell transplant services
• Cancer diagnostic imaging
• Supportive and palliative care
• Physiotherapy and rehabilitation

For prostate cancer, the relevant treatment pathway may involve coordination between uro-oncology, surgical oncology, radiation oncology and medical oncology, depending on the patient's diagnosis.

Patients should confirm the availability of a specific procedure, specialist, medicine or treatment technique before travelling or scheduling treatment.

Recovery After Prostate Cancer Treatment

Recovery depends heavily on the treatment selected.

After Surgery

Recovery after radical prostatectomy can involve temporary changes in urinary control, activity levels and sexual function. Patients generally receive instructions about physical activity, wound care, medications and follow-up.

Pelvic-floor rehabilitation may be recommended for some patients.

After Radiation Therapy

Radiation treatment does not involve surgical recovery, but patients may experience treatment-related effects involving the urinary or digestive systems, fatigue or sexual function.

The timing and severity of side effects vary.

During Hormone Therapy

Hormone therapy can affect the body's androgen levels and may cause effects such as hot flashes, changes in sexual function, fatigue and metabolic or bone-health changes. The specific effects depend on the treatment used and the individual patient.

During Systemic Cancer Treatment

Patients receiving chemotherapy, targeted therapy or immunotherapy may need regular blood tests and clinical monitoring.

The oncology team may adjust treatment depending on response, side effects and other medical findings.

When Should You Seek Medical Attention?

Patients receiving prostate cancer treatment should contact their healthcare team if they develop concerning or worsening symptoms.

Urgent medical assessment may be necessary for symptoms such as:

• Severe or rapidly worsening pain
• Fever or chills
• Difficulty passing urine
• Inability to urinate
• Significant bleeding
• Severe weakness or confusion
• Persistent vomiting
• New severe shortness of breath
• Symptoms suggesting an infection

Patients receiving chemotherapy or other treatments that affect the immune system should follow the emergency instructions provided by their oncology team, because fever during some cancer treatments can require urgent assessment.

Questions to Ask Your Prostate Cancer Specialist

Before deciding on treatment, consider asking:

1. What risk group and stage is my prostate cancer?
2. Is the cancer confined to the prostate?
3. Do I need immediate treatment, or is active surveillance an option?
4. What are my surgery options?
5. What type of radiation therapy would be considered for my cancer?
6. Would hormone therapy be part of my treatment?
7. Would I need chemotherapy, targeted therapy or immunotherapy?
8. What are the potential short- and long-term side effects?
9. How could treatment affect urinary and sexual function?
10. How long will treatment and recovery take?
11. What follow-up tests will I need?
12. Would a second opinion be useful before making a treatment decision?

For patients travelling from another country, it is also useful to ask about the expected number of hospital visits, treatment duration, follow-up requirements and which medical records should be provided before the consultation.

Prostate Cancer Treatment for Patients Considering Care in India

Patients researching treatment outside their home country often compare more than the treatment itself.

Before travelling, consider obtaining copies of:

• PSA reports
• Biopsy and pathology reports
• Pathology slides or blocks where available and relevant
• MRI/CT/PET-CT reports
• Imaging CDs or digital images
• Previous treatment records
• Medication list
• Discharge summaries
• Relevant blood-test results
• Previous oncology consultation notes

A remote specialist review or second opinion may help clarify which additional information is needed before travelling.

Siris Healthcare provides hospital and specialist information for patients researching healthcare in India, while the specific treatment decision should remain with the patient's qualified medical team.

Conclusion

There is no single prostate cancer treatment that is appropriate for every patient.

Surgery, radiation therapy, active surveillance and medical treatments such as hormone therapy, chemotherapy, targeted therapy or immunotherapy each have different roles. The right approach depends on the cancer's stage and risk characteristics, the patient's overall health, previous treatment, expected benefits and risks, and personal treatment priorities.

Medicover Cancer Institute, Arilova, Visakhapatnam provides a cancer-focused setting with uro-oncology, medical oncology, surgical oncology and radiation oncology, along with diagnostic and supportive cancer services.

If you or a family member has been diagnosed with prostate cancer, discussing the pathology, stage and available treatment options with a qualified oncology or uro-oncology specialist is the appropriate next step.

For hospital information and appointment enquiries, you can explore the Medicover Cancer Institute, Arilova, Visakhapatnam page on Siris Healthcare.

7. FAQs

1. What are the main treatment options for prostate cancer?

Treatment can include active surveillance or observation, surgery, radiation therapy, hormone therapy, chemotherapy, targeted therapy and selected immunotherapies. The appropriate option depends on the cancer's risk group, stage, overall health and other clinical factors.

2. Is surgery always necessary for prostate cancer?

No. Some lower-risk prostate cancers may be managed initially with active surveillance rather than immediate surgery or radiation. The decision depends on the cancer's characteristics and the patient's circumstances.

3. When is radiation therapy considered for prostate cancer?

Radiation can be used for selected localized or locally advanced prostate cancers and may also have a role in controlling symptoms in more advanced disease. It may sometimes be combined with hormone therapy.

4. What is hormone therapy for prostate cancer?

Hormone therapy reduces androgen activity, particularly testosterone, which can stimulate prostate cancer growth. It may be used alone or with other treatments depending on the disease stage and clinical situation.

5. Can prostate cancer treatment involve more than one type of therapy?

Yes. Depending on the cancer, doctors may combine surgery, radiation and medical treatments. Combination treatment is particularly relevant in some higher-risk, locally advanced, recurrent or metastatic situations.

6. Which specialist treats prostate cancer?

Prostate cancer may involve a uro-oncologist/urologist, medical oncologist and radiation oncologist. The specialists involved depend on the cancer and the treatment being considered. Medicover Cancer Institute, Arilova lists uro-oncology, medical oncology, surgical oncology and radiation oncology.

7. Can prostate cancer patients get a second opinion before treatment?

Yes. A second oncology or uro-oncology opinion can help a patient better understand the diagnosis, stage and available treatment choices before making a major treatment decision.

8. What should I carry for a prostate cancer consultation?

Bring your PSA history, biopsy and pathology reports, scan reports and images, previous treatment records, medication list and relevant blood-test results. For patients travelling internationally, having complete records available before the consultation can make treatment planning more efficient.

8. Medical Disclaimer

Medical Disclaimer: This article is intended for general educational and informational purposes only. It does not replace professional medical consultation, diagnosis or treatment. Prostate cancer treatment must be individualized according to the patient's pathology, cancer stage, risk group, overall health, previous treatment and other clinical factors. Always consult a qualified urologist, uro-oncologist, medical oncologist or radiation oncologist before making decisions about diagnosis or treatment.